Our History

Intellicig is part of the CN Creative Group, a Bioscience company committed to the development of the next era of nicotine products designed to accelerate and enhance Smoking Harm Reduction.

CNC was formed in September 2008 by the Managing Director and Commercial Director of ELAP Mobility, a long-established company specialising in highly innovative and technical vehicle adaptations for drivers with specific needs. Throughout 30 years, ELAP has placed great emphasis on providing a very high level of customer service and achieving exceptional standards of professionalism, tenets that have naturally migrated to underpin the positive ethos of CNC. The Intellicig Electronic Cigarette was launched as CNC's flagship product and was phenomenally successful, enabling CNC to expand and develop into an innovative Bioscience company; Intellicig continues to thrive as a key trading arm of CNC along with Quit Direct and NRT Direct.

CNC is a profitable company which has enjoyed rapid growth from incubation and, through careful and attentive management, has built a solid foundation from which to successfully progress through several phases of planned development. The global popularity of Intellicig has increased consistently, nurtured from ongoing customer recommendation and the development of trade and retail channels. CNC's bespoke administrative systems allow for continued scalable growth.

Structured re-investment has ensured that CNC's targets for expansion and development were achievable, with many already realised; investment centres cover Research & Development, hardcore infrastructure, including state-of-the-art administration and logistics, latest variant media systems, and of course a valuable, dedicated staff team. Intellicig now employs over 40 full-time staff at our Sales/Admin/Operations Centre in Accrington, which includes full video conferencing facilities, and at the Company’s Bioscience Headquarters in Manchester where ECOpure liquid and Refill Capsules are manufactured within an ISO Class 8 Clean Room.

A nationwide team of trained Retail Customer Managers support Intellicig’s Stockist Network of over 5,000 retail and pharmacy outlets.Internationally, Intellicig is now sold in 26 countries throughout the world with the brand image and identity being localised into 13 languages. Constant brand reinforcement and consistency of message has led to Intellicig now being recognised as the leading manufacturer and supplier of top quality Electronic Cigarettes and E-liquid.

CNC has received backing from Advent Life Sciences, a fund operated by venture capital firm Advent Venture Partners. Advent partner Dale Pfost has become chairman of CN Creative and his colleague Kaasim Mahmood has joined the board. CNC will use the investment to finalise its development of Nicadex, an electronic inhaler nicotine-replacement device to help people quit or reduce smoking. CNC aims to apply for UK medical regulatory approval later this year followed by additional clinical trials, then licence applications in the US and other countries. CNC hopes to start selling Nicadex in 2013.